1401461-22-0

Upstream product

• 6315-89-5 3,4-dimethoxyaniline 
• 480425-35-2 methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate 
• 1401461-05-9 3-[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,4-d]pyrimidin-5-yl]-benzoic acid 
• 1401461-83-3 (5-chlorothiazolo[5,4-d]pyrimidin-7-yl)-(3,4-dimethoxyphenyl)amine 
• 13479-88-4 5,7-dichloro-[1,3]thiazolo[5,4-d]pyrimidine 
• 1401461-84-4 3-[7-(3,4-dimethoxyphenylamino)thiazolo[5,4-d]pyrimidin-5-yl]benzoic acid methyl ester 
• 1341040-36-5 3-(4-aminophenyl)-1,2,4-oxadiazol-5(4H)-one hydrochloride 

Relevant academic research and scientific papers

THIAZOLOPYRIMIDINE COMPOUNDS

The present invention relates to the use of novel pyrrolopyrazine derivatives of formula I: wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.

THIAZOLOPYRIMIDINE COMPOUNDS

The present invention relates to the use of novel pyrrolopyrazine derivatives of formula I: wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.